Metagenomic Sequencing Market Size, Share, Trends & Forecast
The Metagenomic Sequencing Market was valued at USD 0.68 billion in 2024 and is projected to reach USD 3.164 billion by 2035, expanding at a 15.0% CAGR during 2025–2035, according to Market Research Future. Growth is being supported by advances in sequencing technologies, microbiome research, personalized medicine, and genomic research investment.
Reagents and consumables represent the largest product and service segment because they are required throughout sample preparation, amplification, and sequencing workflows. Services are identified as the fastest-growing segment as laboratories increasingly seek specialized sequencing, bioinformatics, data analysis, and consultation capabilities.
Shotgun metagenomic sequencing holds the largest technology segment, offering comprehensive analysis of genetic material within complex microbial communities. 16S rRNA sequencing is identified as the fastest-growing technology segment, particularly for targeted bacterial identification and characterization.
North America remains the largest regional market, supported by research infrastructure and genomics investment, while Asia-Pacific is experiencing rapid expansion as biotechnology investment and healthcare infrastructure develop. Clinical diagnostics, environmental monitoring, agriculture, and microbiome research are among the application areas contributing to broader adoption.
Explore key developments shaping industry transformation:
Physical Therapy Equipment Market Trends